About this trial
Peripheral VA-ECMO is widely used in refractory cardiogenic shock patients as a salvage therapy. In most cases, the femoral artery and vein are used for the vascular approach. Large cannulas are usually used for proper oxygenation, which may cause peripheral limb ischemia. Distal perfusion catheterization (DPC) at the ipsilateral arterial cannula site is recommended to prevent distal limb ischemia. However, there is no consensus on the proper timing of DPC and additional invasive procedures may cause complications during VA-ECMO support. In this analysis, the investigators compare the clinical outcomes of distal limb ischemia complications between the conventional DPC group (DPC at the time of limb ischemia sign) and the preemptive DPC group (DPC at the time of VA-ECMO application).
Eligibility criteria
Qualifiers
Age ≥19 years old
Refractory cardiogenic shock with peripheral VA-ECMO
Informed consent
Disqualifiers
Unwilling or unable to obtain informed consent from the participant or substitute decision-maker
Patients who are currently pregnant, postpartum period within 30 days or are breast-feeding
VA-ECMO application for causes other than cardiogenic shock
Severe coagulopathy
Trial design
Treatments tested in this trial
- Distal perfusion catheterization
Treatment groups
Sponsors and collaborators
Min-Seok Kim
Lead sponsor
Asan Medical Center
Sponsor institution